Immune Deficiencies Flashcards
Reticular Dysgenesis
Autosomal Recessive SCID
AK2 mutation = adenylate kianse 2 in mitochondria responsible for energy production
Causes failure of stem cells to differentiate along MYELOID AND LYMPHOID linage
Failure of production of: Neutrophils Lymphocytes Monocyte/macrophages Platelets Fatal in very early life unless corrected with bone marrow transplantation
Kostmann Syndrome
Autosomal recessive severe congenital neutropenia
Solely affects neutrophil maturation
HAX1 mutation
Cyclic Neutropenia
Autosomal dominant episodic neutropenia
Every 4-6 weeks
Neutrophil elastase (ELA-2) mutation
Leukocyte Adhesion Deficiency
Deficiency of CD18 / B2 integrin
CD11a/CD18 on neutrophil bind to endothelium and facilitate extravasation
Causes:
Very high neutrophils in the blood
Absence of pus formation
Chronic Granulomatous Disease
Failure to generate respiratory burst
NADPH oxidase deficiency
Persistent neutrophil/macrophage accumulation
Formation of Granuloma
Lymphadenopathy and hepatosplenomegaly
Can give IFN-y to activate additional pathways in place of oxidative killing
Nitroblue tetrazolium (NBT) test AND Dihydrorhodamine (DHR) flow cytometry test
Combined = can neutrophils kill through production of oxidative free radicals
Nitroblue tetrazolium NBT
NBT is a dye that changes colour from yellow –> blue, following interaction with hydrogen peroxide
(Nellow to Blue)
Dihydrorhodamine DHR
DHR is oxidised to rhodamine which is strongly fluorescent, following interaction with hydrogen peroxide
Treatment of phagocyte deficiencies
Aggressive management of infection Infection prophylaxis Septrin – antibiotic Itraconazole – anti-fungal Oral/intravenous antibiotics as needed Surgical draining of abscesses
Definitive therapy Bone marrow transplantation ‘Replaces’ defective population Specific treatment for CGD Interferon gamma therapy
Immunodeficiency involving phagocytes
Reticular dysgenesis
Kostmann syndrome (congenital neutropenia)
Leukocyte adhesion deficiency
Chronic granulomatous disease
IL12 /IFN gamma cytokine or receptor deficiency
Activation of the Complement Cascade
Classical = antibody-mediated
Lectin = MBL to microbial cell surface carbohydrates
Alternative = Spontaneous breakdown of C3
Classical Pathway
Antibody-antigen complex (C1–>C4–>C2)
Antibody changes shape –> allows C1 to bind
C1 –> C1a
C1a –> C4 to produce C4b + C4a
C4b + C2 –> C3
Lectin Pathway
Mannose-binding lectin (MBL) C4 and C2
(independent of acquired response)
Activated by the direct binding of MBL to microbial cell surface carbohydrates
Directly stimulates the classical pathway, involving C4 and C2
Alternative Pathway
Spontaneous, C3 BIP pathway
Directly triggered by binding of C3 to bacterial cell wall components
eg lipopolysaccharide of gram negative bacteria
teichoic acid of gram positive bacteria
Not dependent on acquired immune response
Involves factors B, I and P
Features of Complement Deficiency
Susceptibility to infection Particularly with encapsulated bacteria – if alternative / terminal pathway involved Neisseria meningitides (Meningococcus) Streptococcus pneumoniae (Pneumococcus) Group B streptococcus Haemophilus influenza
FHx of meningitis
SLE
If early classical pathway missing
Classical complement pathway is involved in clearance of apoptotic/necrotic cells
Also these immune complexes will do more damage once they have developed as they won’t be solubilised and cleared – role of complement
More likely to get skin disease with SLE
ALSO
SLE causes secondary deficiency
C4 levels falls
Then C3 levels fall
Secondary Causes of Complement Deficiency
SLE
C4 levels falls
Then C3 levels fall
Due to increase consumption in solubilising immune complexes
Auto-immune condition activating C3 convertase
Nephritic Factor
auto-antibodies directed against components of the complement pathway
Associated with Glomerulonephritis (classically membranoproliferative)
Associated with partial lipodystrophy
Abdomainal fat distribution
Loss in upper half of body
Investigation of the Complement Pathway
Measure complement levels
C3 and C4 routine
C1 inhibitor: decreased in hereditary angioedema
Functional complement tests
CH50 classical pathway
AP50 alternative pathway
Immunodeficiency involving complement
Classical pathway deficiencies MBL deficiency Alternative pathway deficiencies C3 deficiency Terminal pathway deficiencies
Phenotype of SCID
SCID --> Graft vs Host Disease Unwell by 3 months Infections of all types Failure to thrive Unusual skin disease Maternal lymphocyte colonise infants bone marrow --> Graft vs Host FHx of early infant death
Protected for first 3 months:
Maternal IgG crosses placenta
Maternal antibodies protect neonate for first 3 months of life
IgG in colostrum - Neonate gut can still absorb antibodies
X-Linked SCID
X-linked SCID = 45% of all SCID
Chromosome X: IL-2R gamma chain mutation (Xq13.1)
Receptor chain is shared by IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21 RECEPTORS
Inability to respond to cytokines –> arrested T cell and NK development –> don’t produce
Able to produce immature B cells
Phenotype
Low/Absent T cells
Normal/High B cells (immature)
Poorly differentiated lymphoid tissue and thymus